Significant differences in the presence of BRAF mutations were calculated for age (p < 0.001, Figure 1), localization of the primary tumor (p < 0.001), tumor stage at initial diagnosis (p = 0.003), type of primary melanoma (p < 0.001) and tumor thickness (p = 0.005). Here, BRAF is linked to melanoma.